Company / Current Liabilities per Share
Apogee Therapeutics, Inc. Current Liabilities per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.52
FY2024
5-year range
$0.52 / $4.05
FY2022-FY2024
Trend
-37.1%
vs FY2023
Sector context
#154 of 210
Health Care
What the data says
At $0.52, Apogee Therapeutics, Inc.'s current liabilities per share ranks #57 of 210 in the Health Care sector. Improved from $4.05 to $0.52 over the past 2 years.
Based on SEC 10-K filings.
0.52 in FY2024.
Improved from $4.05 to $0.52 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 210 in Health CareTop 27% of 210This company $0.52 Sector average $23.79
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 37.1% year-over-year.
- Ranks #154 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.52 | -37.1% |
| FY2023 | $0.82 | -79.7% |
| FY2022 | $4.05 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026